Displaying 1 through 8 of 15 Next Page >>
|
| Guideline Issued for Treating Sleep, Constipation, Sexual Problems in Parkinson’s Disease |
| Wednesday, March 24, 2010 |
| ST. PAUL, Minn. – The American Academy of Neurology has issued a new guideline recommending the most effective treatments to help people with Parkinson’s disease who experience sleep, constipation, and sexual problems, which are common but often underrecognized symptoms. The guideline is published in the March 16, 2010, issue of Neurology®, the medical |
| |
| MJFF Awards $2.8 Million to Drive Development of Parkinson's Disease Biomarker Pipeline |
| Friday, February 12, 2010 |
| The Michael J. Fox Foundation for Parkinson’s Research today announced more than $2.8 million in awards for 13 new projects to speed the discovery of biomarkers of PD. The development of biomarkers is of critical importance to increasing the speed and efficiency of PD therapeutic development, allowing scientists and clinicians to more accurately identify |
| |
| Industrial Cleaner Linked to Increased Risk of Parkinson’s Disease |
| Tuesday, February 9, 2010 |
| Sunnyvale, CA – February 8, 2010
The Parkinson’s Institute and Clinical Center (PI) is excited to announce the publication of the report, "Parkinson’s Disease Risk is Increased in Discordant Twins Exposed to Specific Solvents" by The American Academy of Neurology. Samuel M. Goldman, MD, MPH and colleagues at the Parkinson’s Institute in Sunnyvale found |
| |
| Agent Orange Component Linked to Parkinson’s Disease |
| Monday, September 14, 2009 |
Workplace use of the herbicide
2,4-dichlorophenoxyacetic acid (2,4-D), a key constituent of the
defoliant Agent Orange, is associated with an increased risk of
developing Parkinson’s disease, according to a report published in the
Archives of Neurology by Caroline M. Tanner, M.D., Ph.D., Director of
Clinical Research at the Parkinson’s Institute, and her colleagues at
eight Parkinson’s disease research centers in the U.S. and Canada. Two
other pesticides – paraquat and permethrin – were also associated with
higher risk of Parkinson’s disease. |
| |
| Genetics Research Project Launched |
| Friday, March 13, 2009 |
| 23andMe, Inc., an industry leader in personal genetics, announced today that it has launched a Parkinson’s disease initiative in collaboration with the Parkinson’s Institute and Clinical Center (“PI”) and The Michael J. Fox Foundation (“MJFF”). Press Release
|
| |
| Dr.J. William Langston Awarded 2008 Donald Calne Lectureship |
| Friday, January 9, 2009 |
| The Parkinson’s Institute and Clinical Center, (PI) is, is very excited to announce Dr. J. William Langston has been awarded the sixth annual Donald Calne Lectureship awarded by the Parkinson Society of Canada.
|
| |
| Google Founder Reveals Risk of Parkinson's in his genes |
| Tuesday, October 7, 2008 |
| Google cofounder Sergey Brin has finally started a personal blog, and
he went from describing his title choice to revealing some significant
health news: he is at potentially high risk for contracting Parkinson's
disease.
|
| |
| Omeros Corp. and Parkinson's Institute collaborate on Motion Disorder Target |
| Wednesday, September 17, 2008 |
| Seattle, Washington and Sunnyvale, California – September 17, 2008 – Omeros Corporation and The Parkinson’s Institute and Clinical Center today announced that they have entered into a collaboration to evaluate a novel target, proprietary to Omeros, for the treatment of movement disorders.
|
| |
Next Page >>
|
